Clinical Trial

Individualized Smoking Cessation Program

Study Description

Evaluation of an Intensive Individualized Smoking Cessation Program Delivered by Pharmacists

This study aims to look at the efficacy and impact of a pharmacist-led smoking cessation program. It will assess an intensive program and an abbreviated program, with the latter being evaluated for feasibility in community pharmacies. Participants will be in one of three groups: intensive, abbreviated or usual care. Smoking abstinence rates, quality of life, self-efficacy will be compared. Additionally, a cost-effectiveness analysis will be executed to determine the feasibility of customized smoking cessation programs in community pharmacies across Newfoundland and Labrador.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Behavioral - Intensive Smoking Cessation Group

This group will meet with the pharmacist more frequently and for longer periods than other groups.

Behavioral - Abbreviated Smoking Cessation Group

This group will meet with the pharmacist less frequently and for shorter periods in comparison to the intensive group.

Additional Information

Official Study Title

Efficacy and Cost-Effectiveness of an Intensive and Abbreviated Individualized Smoking Cessation Support Program Delivered by Pharmacists: A Randomized Controlled Trial

Clinical Trial ID

NCT03597607

ParticipAid ID

azppZd